{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:50:58Z","timestamp":1792165858751,"version":"4.4.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging"],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Implicated in both aging and Alzheimer\u2019s disease (AD), mammalian target of rapamycin (mTOR) is overactive in AD brain and lymphocytes. Stimulated by growth factors such as insulin, mTOR monitors cell health and nutrient needs. A small molecule oral drug candidate for AD, simufilam targets an altered conformation of the scaffolding protein filamin A (FLNA) found in AD brain and lymphocytes that induces aberrant FLNA interactions leading to AD neuropathology. Simufilam restores FLNA\u2019s normal shape to disrupt its AD-associated protein interactions.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We measured mTOR and its response to insulin in lymphocytes of AD patients before and after oral simufilam compared to healthy control lymphocytes.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> mTOR was overactive and its response to insulin reduced in lymphocytes from AD versus healthy control subjects, illustrating another aspect of insulin resistance in AD. After oral simufilam, lymphocytes showed normalized basal mTOR activity and improved insulin-evoked mTOR activation in mTOR complex 1, complex 2, and upstream and downstream signaling components (Akt, p70S6K and phosphorylated Rictor). Suggesting mechanism, we showed that FLNA interacts with the insulin receptor until dissociation by insulin, but this linkage was elevated and its dissociation impaired in AD lymphocytes. Simufilam improved the insulin-mediated dissociation. Additionally, FLNA\u2019s interaction with Phosphatase and Tensin Homolog deleted on Chromosome 10 (PTEN), a negative regulator of mTOR, was reduced in AD lymphocytes and improved by simufilam.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> Reducing mTOR\u2019s basal overactivity and its resistance to insulin represents another mechanism of simufilam to counteract aging and AD pathology. Simufilam is currently in Phase 3 clinical trials for AD dementia.<\/jats:p>","DOI":"10.3389\/fragi.2023.1175601","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T10:19:11Z","timestamp":1688033951000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer\u2019s disease patient lymphocytes"],"prefix":"10.3389","volume":"4","author":[{"given":"Hoau-Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chieh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Nikolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay H.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.neuropharm.2017.09.016","article-title":"Reduced brain insulin signaling: A seminal process in Alzheimer\u2019s disease pathogenesis","volume":"136","author":"Bloom","year":"2018","journal-title":"Neuropharmacology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1152\/physrev.00038.2014","article-title":"mTOR in brain physiology and pathologies","volume":"95","author":"Bockaert","year":"2015","journal-title":"Physiol. Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"22085","DOI":"10.1002\/ddr.22085","article-title":"Targeting \u03b17 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug development","volume":"2023","author":"Burns","year":"2023","journal-title":"Drug Dev. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.20517\/2347-8659.2017.50","article-title":"Altered filamin A enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer\u2019s disease","volume":"4","author":"Burns","year":"2017","journal-title":"Neuroimmunol. Neuroinflammation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/acel.12057","article-title":"mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies","volume":"12","author":"Caccamo","year":"2013","journal-title":"Aging Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and tau: Effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1074\/jbc.M110.180638","article-title":"Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism","volume":"286","author":"Caccamo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.2147\/NDT.S75717","article-title":"Activation of mTOR: A culprit of Alzheimer\u2019s disease?","volume":"11","author":"Cai","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/jnr.23011","article-title":"Mammalian target of rapamycin: A valid therapeutic target through the autophagy pathway for alzheimer's disease?","volume":"90","author":"Cai","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"25056","DOI":"10.1074\/jbc.M200066200","article-title":"Beta -Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes","volume":"227","author":"Dineley","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1128\/MCB.24.1.200-216.2004","article-title":"mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1\/eukaryotic translation initiation factor 4E","volume":"24","author":"Fingar","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1177\/1947601911407325","article-title":"PTEN tumor suppressor network in PI3K-Akt pathway control","volume":"1","author":"Georgescu","year":"2010","journal-title":"Genes Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1471-4159.2004.02949.x","article-title":"Activation of Akt\/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology","volume":"93","author":"Griffin","year":"2005","journal-title":"J. Neurochem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3233\/JAD-160702","article-title":"Mitochondrial dysfunction and synaptic transmission failure in Alzheimer's disease","volume":"57","author":"Guo","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"27096","DOI":"10.1074\/jbc.M301003200","article-title":"Interaction of filamin A with the insulin receptor alters insulin-dependent activation of the mitogen-activated protein kinase pathway","volume":"278","author":"He","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature11861","article-title":"mTOR is a key modulator of ageing and age-related disease","volume":"493","author":"Johnson","year":"2013","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1128\/MCB.00601-09","article-title":"mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling","volume":"30","author":"Julien","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1210\/en.2004-0921","article-title":"Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: Possible involvement in obesity-linked insulin resistance","volume":"146","author":"Khamzina","year":"2005","journal-title":"Endocrinology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.tem.2019.09.005","article-title":"Growth factor-dependent and-independent activation of mTORC2","volume":"31","author":"Knudsen","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","article-title":"The neurology of mTOR","volume":"84","author":"Lipton","year":"2014","journal-title":"Neuron"},{"key":"B25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.2174\/1567205015666180223093020","article-title":"Oxidative stress and decreased mitochondrial superoxide dismutase 2 and peroxiredoxins 1 and 4 based mechanism of concurrent activation of AMPK and mTOR in alzheimer's disease","volume":"15","author":"Majd","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e25416","DOI":"10.1371\/journal.pone.0025416","article-title":"Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits","volume":"6","author":"Majumder","year":"2011","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.90.OC7.5","article-title":"A novel filamin A-binding molecule may significantly enhance somatostatin receptor type 2 antitumoral actions in growth hormone-secreting PitNET cells","author":"Marra","year":"2023","journal-title":"25th European Congress of Endocrinology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13195-019-0535-7","article-title":"Association between increased levels of amyloid-\u03b2 oligomers in plasma and episodic memory loss in Alzheimer's disease","volume":"11","author":"Meng","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"B29","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/acel.12194","article-title":"Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction","volume":"13","author":"Miller","year":"2014","journal-title":"Aging Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s0306-4522(01)00460-2","article-title":"Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease","volume":"110","author":"Nagele","year":"2002","journal-title":"Neuroscience"},{"key":"B31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4161\/cam.5.2.14401","article-title":"The filamins: Organizers of cell structure and function","volume":"5","author":"Nakamura","year":"2011","journal-title":"Cell Adh Migr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jalz.2016.08.015","article-title":"mTOR and neuronal cell cycle re-entry: How impaired brain insulin signaling promotes Alzheimer's disease","volume":"13","author":"Norambuena","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B33","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2741\/s310","article-title":"The role of mTOR signaling in Alzheimer disease","volume":"4","author":"Oddo","year":"2012","journal-title":"Front. Biosci. Sch. Ed."},{"key":"B34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000095562","article-title":"Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease","volume":"22","author":"Paccalin","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","article-title":"mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy","volume":"84","author":"Perluigi","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.canlet.2018.08.002","article-title":"cAMP\/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells","volume":"435","author":"Peverelli","year":"2018","journal-title":"Cancer Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1016\/j.yexcr.2008.06.004","article-title":"Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration","volume":"314","author":"Ravid","year":"2008","journal-title":"Exp. Cell Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.mrrev.2008.06.001","article-title":"The mTOR pathway and its role in human genetic diseases","volume":"659","author":"Rosner","year":"2008","journal-title":"Mutat. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/gtc.12366","article-title":"Mammalian target of rapamycin (mTOR) complex 2 regulates filamin A-dependent focal adhesion dynamics and cell migration","volume":"21","author":"Sato","year":"2016","journal-title":"Genes cells"},{"key":"B41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.4161\/cc.10.11.15824","article-title":"The insulin receptor substrate (IRS) proteins: At the intersection of metabolism and cancer","volume":"10","author":"Shaw","year":"2011","journal-title":"Cell Cycle"},{"key":"B43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3109\/10409238.2011.618113","article-title":"Mammalian TOR signaling to the AGC kinases","volume":"46","author":"Su","year":"2011","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1101\/lm.1067808","article-title":"Role of the phosphoinositide 3 kinase\u2013Akt\u2013mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex","volume":"15","author":"Sui","year":"2008","journal-title":"Learn Mem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","article-title":"Molecular neurobiology of mTOR","volume":"341","author":"Switon","year":"2017","journal-title":"Neuroscience"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","article-title":"Regulation and metabolic functions of mTORC1 and mTORC2","volume":"101","author":"Szwed","year":"2021","journal-title":"Physiol. Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.bbamcr.2015.03.003","article-title":"mTor mediates tau localization and secretion: Implication for Alzheimer's disease","volume":"1853","author":"Tang","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.3389\/fimmu.2018.02852","article-title":"Filamin A phosphorylation at serine 2152 by the serine\/threonine kinase Ndr2 controls TCR-induced LFA-1 activation in T cells","volume":"9","author":"Waldt","year":"2018","journal-title":"Front. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.1523\/JNEUROSCI.0354-12.2012","article-title":"Reducing amyloid-related Alzheimer\u2019s disease pathogenesis by a small molecule targeting filamin A","volume":"32","author":"Wang","year":"2012","journal-title":"J. Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2017.03.016","article-title":"PTI-125 binds and reverses an altered conformation of filamin A to reduce Alzheimer's disease pathogenesis","volume":"55","author":"Wang","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"B52","doi-asserted-by":"publisher","first-page":"31547","DOI":"10.1074\/jbc.M212532200","article-title":"Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation","volume":"278","author":"Wang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"256","DOI":"10.14283\/jpad.2020.6","article-title":"PTI-125 reduces biomarkers of Alzheimer\u2019s disease in patients","volume":"7","author":"Wang","year":"2020","journal-title":"J. Prev. Alzheimer's Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/ncb2877","article-title":"Crosstalk between mTOR complexes","volume":"15","author":"Xie","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jprot.2019.03.017","article-title":"ANXA2(Tyr23) and FLNA(Ser2152) phosphorylation associate with poor prognosis in hepatic carcinoma revealed by quantitative phosphoproteomics analysis","volume":"200","author":"Xing","year":"2019","journal-title":"J. Proteomics"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3390\/nu9111176","article-title":"The role of mammalian target of rapamycin (mTOR) in insulin signaling","volume":"9","author":"Yoon","year":"2017","journal-title":"Nutrients"}],"container-title":["Frontiers in Aging"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fragi.2023.1175601\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T10:19:14Z","timestamp":1688033954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fragi.2023.1175601\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":57,"alternative-id":["10.3389\/fragi.2023.1175601"],"URL":"https:\/\/doi.org\/10.3389\/fragi.2023.1175601","relation":{},"ISSN":["2673-6217"],"issn-type":[{"value":"2673-6217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"article-number":"1175601"}}